We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





Assistant Cell Image Analyzer for Hematology Labs Released

By LabMedica International staff writers
Posted on 19 Jul 2012
AACC 2012: A cell image analyzer for hematology laboratories automates and simplifies the cell differential process by locating and preclassifying white blood cells.

Called EasyCell and manufactured by Medica Corporation (Bedford, MA, USA), the analyzer employs optical pattern recognition software to automatically locate white cells on a blood smear. More...
It digitally stores their images, preclassifies, and then presents them for review—grouped by cell type—on a liquid crystal display (LCD) display.

The analyzer also presents images of red cells and platelets, enabling red cell morphology and platelet estimates. With its 30-position carousel, the EasyCell offers walkaway operation and a stat slide port permits immediate testing without disrupting a sample run.

EasyCell reduces sample review times by 50% over the manual differentiation process using microscopes, while helping the technologist achieve improved efficiency, accuracy, and precision.

Doug Moe, vice president of business development, Medica Corporation, said, “The EasyCell assistant lowers cost by substantially cutting the time technologists require to perform manual blood cell differentials and correctly classify normal cells."

A clinical evaluation at the Children’s Hospital Boston (Boston, MA, USA) confirmed the EasyCell efficacy in the hematology laboratory environment.

In an announcement at the 2012 Annual Meeting of the American Association for Clinical Chemistry (AACC) Expo being held July 15-19, 2012 in Los Angeles (CA, USA), the company said it is now accepting orders for the EasyCell solution and will have instruments available for global shipment during the third quarter of 2012.

Related Links:

Medica Corporation
Children’s Hospital Boston




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
All-in-One Molecular System
AIO M160
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Lead author Professor Chamindie Punyadeera. (Image Credit: Griffith University)

Breath Analysis Shows Promise for Distinguishing Cancerous from Benign Lung Nodules

Lung nodules are frequently detected during imaging, but distinguishing malignant from benign findings can require invasive procedures. Some patients undergo biopsies, bronchoscopy, or surgery before learning... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.